Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report

Rapidly progressive interstitial lung disease is typically associated with clinically amyopathic dermatomyositis and the anti-melanoma differentiation associated gene 5 antibody, a condition with high mortality and resistance to classic immunosuppression. Recent reports have described the efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Conca, Walter, Weheba, Ihab, Abouzied, Mohei-Eldin, Abdelsayed, Abeer, Aleyouni, Yousif, Al‐Mutairy, Eid, Bakshi, Nasir, Khalid, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770219/
https://www.ncbi.nlm.nih.gov/pubmed/33384600
http://dx.doi.org/10.3389/fphar.2020.585761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770219/
https://www.ncbi.nlm.nih.gov/pubmed/33384600
http://dx.doi.org/10.3389/fphar.2020.585761

Ejemplares similares